Background. Studies of the coronary vasodilating properties of isoflur
ane have produced inconsistent results. Isoflurane has been reported t
o cause minimal or no coronary vasodilation, mild dose-related vasodil
ation, or even near-maximal coronary vasodilation. The current study w
as performed to clarify the direct coronary vasodilating potency of is
oflurane. Methods. We determined the vasodilating properties of isoflu
rane in regionally perfused swine myocardium. Six domestic swine were
anesthetized with pentobarbital and fentanyl. The left anterior descen
ding artery (LAD) was cannulated and perfused with blood drawn from th
e carotid artery and passed thorough a membrane oxygenator. LAD arteri
al flow was controlled by a calibrated roller pump with continuous dig
ital readout, and LAD arterial pressure was measured directly. The ant
erior interventricular vein was cannulated and dimension crystals plac
ed in the LAD-perfused myocardium. The vasodilation response to 0, 1,
2, and 3% isoflurane administered via the membrane oxygenator was dete
rmined and compared to maximal vasodilation produced by regional intra
coronary administration of adenosine. Results: Systemic blood pressure
and heart rate remained constant throughout the experiment. With 3% i
soflurane, systolic shortening and regional myocardial oxygen consumpt
ion decreased by 60 and 20%, respectively. The same concentration incr
eased coronary blood flow by 51 +/- 34% and reduced coronary vascular
resistance by 32.9 +/- 11.0%. Neither coronary blood flow nor coronary
vascular resistance was affected with 1% isoflurane. Regional coronar
y administration of adenosine produced much greater changes in both co
ronary blood flow (+591%) and coronary vascular resistance (-92.5%). I
soflurane increased the venous oxygen content of the anterior interven
tricular vein in a dose-dependent fashion from 4.85 vol% at control to
6.17, 7.01, and 8.63 vol% at 1, 2, and 3% isoflurane, respectively. C
onclusions: We conclude that isoflurane is a mild dose-dependent coron
ary vasodilator. At a 1% concentration, the coronary vasodilating prop
erties of isoflurane are minimal.